Why the study?
Does coumadin therapy resolve late thrombotic obstruction in a patient with an aortic bioprosthetic valve?
Does coumadin therapy resolve late thrombotic obstruction in a patient with an aortic bioprosthetic valve?
Oral anticoagulation with coumadin can successfully treat late thrombotic obstruction of an aortic bioprosthetic valve.
May support coumadin for select late aortic bioprosthetic thrombosis; hypothesis-generating case report requiring prospective validation.
Thrombotic obstruction of aortic bioprostheses is rare. Few cases have been reported involving the use of the Carpentier-Edwards (CE) prosthesis, the Hancock bioprosthesis, or the Medtronic Intact porcine valve. Thrombolytic therapy for mechanical valve thrombosis has been used frequently even though it is known to carry a high risk of embolism and recurrence. However, the use of this therapy was reported for the first time only recently, in a case of acute aortic thrombosis which occurred 3 1/2 months after bioprosthesis insertion. We report a case of late progressive thrombotic obstruction of a CE aortic valve 3 years after insertion. The case was successfully treated with coumadin therapy, as confirmed by serial Doppler echocardiographic examinations and a 3-year follow-up.
No takes yet. Share an insight, caveat, or question.
Juliard et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: